024 Pharma, Inc.: 10-Q filed 2011-11-14

Name: 024 Pharma, Inc.: 10-Q filed 2011-11-14
Creator: 024 Pharma, Inc.

What 024 Pharma, Inc. reported in its quarterly report filed 2011-11-14 (fiscal Q3 2011): 35 published measures, 94 facts as tagged in accession 0001185185-11-001961.

This filing

Form: 10-Q (quarterly report)
Filed: 2011-11-14
Fiscal period: fiscal Q3 2011
Accession: 0001185185-11-001961 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All 024 Pharma, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2011-09-30	1,187,784	USD
At 2010-12-31	1,327,519	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2011-09-30	-199,229	USD
At 2010-12-31	143,788	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2011-09-30	77,572	USD
At 2010-12-31	1,141,944	USD
At 2010-09-30	1,238,344	USD
At 2009-12-31	190,350	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	-54,727	USD	92
2011-01-01 to 2011-09-30	-237,698	USD	273
2010-07-01 to 2010-09-30	-118,009	USD	92
2010-01-01 to 2010-09-30	1,149,797	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-01-01 to 2011-09-30	-127,459	USD	273
2010-01-01 to 2010-09-30	-39,394	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2010-01-01 to 2010-09-30	12,612	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-01-01 to 2011-09-30	-29,774	USD	273
2010-01-01 to 2010-09-30	1,100,000	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2011-01-01 to 2011-09-30	-907,139	USD	273
2010-01-01 to 2010-09-30	-12,612	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2011-09-30	-12,736,666	USD
At 2010-12-31	-12,498,968	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	606,774,858	shares	92
2011-01-01 to 2011-09-30	605,241,917	shares	273
2010-07-01 to 2010-09-30	604,415,387	shares	92
2010-01-01 to 2010-09-30	601,904,764	shares	273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	606,774,858	shares	92
2011-01-01 to 2011-09-30	605,241,917	shares	273
2010-07-01 to 2010-09-30	604,415,387	shares	92
2010-01-01 to 2010-09-30	3,889,788,514	shares	273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Unit	Days
2011-07-01 to 2011-09-30	USD/shares	92
2011-01-01 to 2011-09-30	USD/shares	273
2010-07-01 to 2010-09-30	USD/shares	92
2010-01-01 to 2010-09-30	USD/shares	273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Unit	Days
2011-07-01 to 2011-09-30	USD/shares	92
2011-01-01 to 2011-09-30	USD/shares	273
2010-07-01 to 2010-09-30	USD/shares	92
2010-01-01 to 2010-09-30	USD/shares	273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2011-07-01 to 2011-09-30	USD	92
2011-01-01 to 2011-09-30	USD	273
2010-07-01 to 2010-09-30	USD	92
2010-01-01 to 2010-09-30	USD	273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2011-09-30	11,783	USD
At 2010-12-31	35,276	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	-99,390	USD	92
2011-01-01 to 2011-09-30	-350,582	USD	273
2010-07-01 to 2010-09-30	-131,763	USD	92
2010-01-01 to 2010-09-30	-377,662	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2011-09-30	1,122,803	USD
At 2010-12-31	1,232,309	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	5,058	USD	92
2011-01-01 to 2011-09-30	13,152	USD	273
2010-07-01 to 2010-09-30	3,206	USD	92
2010-01-01 to 2010-09-30	9,213	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2011-09-30	1,387,013	USD
At 2010-12-31	1,183,731	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2011-09-30	18,017	USD
At 2010-12-31	4,284	USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

Period	Value	Unit	Days
2011-01-01 to 2011-09-30	29,774	USD	273

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	147,519	USD	92
2011-01-01 to 2011-09-30	478,067	USD	273
2010-07-01 to 2010-09-30	153,389	USD	92
2010-01-01 to 2010-09-30	451,702	USD	273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2011-09-30	5,899	USD
At 2010-12-31	1,106	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	48,129	USD	92
2011-01-01 to 2011-09-30	127,485	USD	273
2010-07-01 to 2010-09-30	21,626	USD	92
2010-01-01 to 2010-09-30	74,040	USD	273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	16,044	USD	92
2011-01-01 to 2011-09-30	44,042	USD	273
2010-07-01 to 2010-09-30	22,287	USD	92
2010-01-01 to 2010-09-30	68,957	USD	273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	147,519	USD	92
2011-01-01 to 2011-09-30	458,485	USD	273
2010-07-01 to 2010-09-30	153,389	USD	92
2010-01-01 to 2010-09-30	451,702	USD	273

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2011-09-30	9,850,172	USD
At 2010-12-31	8,888,090	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2011-09-30	-13,940	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2011-09-30	53,198	USD
At 2010-12-31	59,934	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2011-09-30	16,616	USD
At 2010-12-31	24,975	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2011-01-01 to 2011-09-30	-13,940	USD	273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2011-01-01 to 2011-09-30	10,647	USD	273
2010-01-01 to 2010-09-30	8,168	USD	273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	44,663	USD	92
2011-01-01 to 2011-09-30	112,884	USD	273
2010-07-01 to 2010-09-30	13,754	USD	92
2010-01-01 to 2010-09-30	1,527,459	USD	273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2011-01-01 to 2011-09-30	-13,733	USD	273
2010-01-01 to 2010-09-30	-9,938	USD	273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2011-01-01 to 2011-09-30	-4,793	USD	273
2010-01-01 to 2010-09-30	-879	USD	273

Inspect the source

Entity: 024 Pharma, Inc. / CIK 0001307969
Captured: 2026-09-22 19:42 UTC
SEC response SHA-256: fa80a3a5298b889b9a628ab89f7898d6e74042ef6b4e6bad6f33e27bd54f1993

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001307969.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))